Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
NCT ID: NCT00655356
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were collected from the baseline visit through the final study visit, 6 months after final study treatment.
Study: NCT00655356
Study Brief: Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Autologous Fibroblasts Patients treated with autologous fibroblasts (azficel-T). None None 8 98 32 98 View
Placebo Patients treated with placebo solution. None None 7 99 33 99 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Spinal Column Stenosis NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Menorrhagia NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (Unspecified) View
Dysmenorrhoea NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (Unspecified) View
Endometriosis NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (Unspecified) View
Muscular Weakness NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (Unspecified) View
Cervical Vertebral Fracture NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (Unspecified) View
Nephrectomy NON_SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA (Unspecified) View
Appendicitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Coronary Artery Disease NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (Unspecified) View
Rib Fracture NON_SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (Unspecified) View
Impaired Gastric Emptying NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Uterine Leiomyoma NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (Unspecified) View
Subarachnoid Hemorrhage NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (Unspecified) View
Spondylolisthesis NON_SYSTEMATIC_ASSESSMENT Congenital, familial and genetic disorders MedDRA (Unspecified) View
Cardiac Arrest NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (Unspecified) View
Retinal Detachment NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (Unspecified) View
Staphylococcal Infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View
Angina Pectoris NON_SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site bruising NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Injection site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Injection site haemorrhage NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (Unspecified) View